Medigen Biotechnology Corp. (TPEX:3176)

Medigen Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,249	4,514	4,514	6,243	4,685	7,999
Market Cap Growth	-13.84%	-	-27.70%	33.24%	-41.43%	-2.78%
Enterprise Value	5,842	6,329	6,470	8,430	7,328	10,273
Last Close Price	30.50	32.40	32.40	44.80	33.60	57.40
PS Ratio	2.68	2.85	3.29	5.39	4.44	2.04
PB Ratio	0.90	0.96	0.90	1.25	0.72	1.25
P/TBV Ratio	2.92	3.10	3.05	4.20	2.25	3.52
P/FCF Ratio	-	-	-	-	-	21.32
P/OCF Ratio	104.79	111.32	119.03	-	-	15.44
EV/Sales Ratio	3.69	4.00	4.71	7.28	6.94	2.62
EV/EBITDA Ratio	-	-	-	-	-	10.62
EV/EBIT Ratio	-	-	-	-	-	13.17
EV/FCF Ratio	-189.05	-	-	-	-	27.38
Debt / Equity Ratio	0.19	0.19	0.20	0.57	0.43	0.15
Debt / EBITDA Ratio	57.31	57.31	-	-	-	1.02
Debt / FCF Ratio	-	-	-	-	-	2.64
Net Debt / Equity Ratio	-0.33	-0.33	-0.31	-0.34	-0.36	-0.31
Net Debt / EBITDA Ratio	175.94	175.94	23.46	1.60	1.58	-2.07
Net Debt / FCF Ratio	50.94	50.94	91.88	3.18	1.84	-5.35
Asset Turnover	0.25	0.25	0.18	0.13	0.12	0.55
Inventory Turnover	1.11	1.11	1.04	0.87	1.34	2.55
Quick Ratio	3.80	3.80	3.19	1.81	5.32	3.60
Current Ratio	4.68	4.68	3.96	2.05	6.40	4.62
Return on Equity (ROE)	-6.07%	-6.07%	-4.43%	-25.64%	-29.95%	19.60%
Return on Assets (ROA)	-1.52%	-1.52%	-1.78%	-8.33%	-11.46%	6.79%
Return on Invested Capital (ROIC)	-4.76%	-4.74%	-6.43%	-33.40%	-39.08%	18.75%
Return on Capital Employed (ROCE)	-2.90%	-2.90%	-3.80%	-21.50%	-18.70%	10.90%
Earnings Yield	-2.56%	-2.41%	-4.54%	-8.99%	-14.42%	-0.66%
FCF Yield	-0.73%	-0.69%	-0.38%	-8.68%	-27.46%	4.69%
Buyback Yield / Dilution	-	-	0.03%	-0.16%	-0.11%	0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.